Navigation Links
CuraGen Appoints Clinical Oncologist as VP of Medical Development
Date:9/26/2007

BRANFORD, Conn., Sept. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Ronit Simantov, M.D., has joined CuraGen as Vice President of Medical Development.

Dr. Simantov is a seasoned and accomplished clinical oncologist with experience obtained in both pharmaceutical and academic positions. In her previous position at Bayer Healthcare Pharmaceuticals, Dr. Simantov played a key role in the successful clinical development, registration, and launch of Nexavar(R) (sorafenib), which was approved by the FDA in 2005. During her academic career, Dr. Simantov conducted research into the modulation of angiogenesis in cancer, and has published extensively in peer-reviewed journals.

"We believe that Ronit has the right expertise to assist us in the evaluation of the data being generated from our three clinical oncology programs, and to support the preparations being made to potentially transition one or more of these products into Phase III during 2008," commented Timothy Shannon, M.D., President and Chief Executive Officer of CuraGen. "Her addition to the team currently in place provides CuraGen with a talented, and very experienced, group of individuals who have a history of successfully bringing products through clinical development and onto market."

Prior to joining CuraGen, Dr. Simantov held positions of increasing responsibility at Bayer Healthcare Pharmaceuticals from June 2003 through August 2007, and was most recently Director, Global Clinical Leader, Oncology during which she was responsible for the global development of Nexavar(R) in non-small cell lung cancer (NSCLC) and medical lead for regulatory sub
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Wheaton, Illinois (PRWEB) May 04, 2015 ... treatment options for patients with arm and hand ... rehabilitation exoskeleton at its Oakbrook Terrace network site. ... foundation, the Armeo®Spring is a highly-regarded treatment option ... In acquiring the Armeo®Spring, Marianjoy becomes one of ...
(Date:5/1/2015)... 2015 OncoTAb, Inc., a ... company, announced that Pinku Mukherjee, Ph.D. has received the ... of Governors’ highest faculty honor. Mukherjee received the award, ... for her innovative research and development of cancer diagnostics ... a crowning moment in my scientific career,” said Mukherjee, ...
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... , May 1, 2015 A ... for antithrombotic drugs will reach $22.4bn in 2019. That ... World Industry and Market Prospects 2015-2025 , ... that investigation is to provide forecasts and qualitative analyses ... information publisher and consultancy in London, UK ...
Breaking Biology Technology:Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5
... , London, July 20 There ... in the pharmaceutical and biotechnology space. While the economic downturn and ... for the recent M&A mania, which has including four mega M&As ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
... , EDMONTON, July 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... (MS), today announced financial and operational results for the three ... phase III MAESTRO-01 trial has completed the last patient last ... the second half of this year. This is the first ...
... 17 Encorium Group, Inc. (Nasdaq: ... organization (CRO) that provides design, development, and management capabilities ... the world,s leading pharmaceutical companies, today announced that is ... U.S. business to Pierrel Research USA, Inc., a wholly-owned ...
Cached Biology Technology:Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities 2BioMS Medical announces second quarter 2009 results 2BioMS Medical announces second quarter 2009 results 3BioMS Medical announces second quarter 2009 results 4BioMS Medical announces second quarter 2009 results 5BioMS Medical announces second quarter 2009 results 6BioMS Medical announces second quarter 2009 results 7BioMS Medical announces second quarter 2009 results 8BioMS Medical announces second quarter 2009 results 9Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 2Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 3Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 4
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... , April 2, 2015 At its ... Salt Lake City , the American College of ... five new directors to its Board.  Members of the ... ACMG and for forming and advancing its policies and ... genetics profession. "It,s an eventful time in ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Technologies was chosen for multiple reasons: to initiate a ... provide society with security of energy supply and to ... a European graduate school is thought to be the ... to foster the development of excellent young scientists, presenting ...
... of years, humans have evolved to naturally understand things like ... researcher has found there is an ever-widening gap between what ... to be successful adults in today,s modern society. Schools have ... but in the U.S. more may need to be done. ...
... Netherlands, June 09, 2009 / b3c newswire / ... the Netherlands Organisation for Applied Scientific Research TNO today ... to further develop Amarna’s viral gene delivery platform ... methods for the manufacture, formulation and testing of viral ...
Cached Biology News:MU study finds connection between evolution, classroom learning 2Amarna Therapeutics B.V. and TNO announce SVac research and development partnership 2Amarna Therapeutics B.V. and TNO announce SVac research and development partnership 3
... Dithiothreitol DTT White solid.. PACKAGED UNDER ... thiols, so reaction is "driven" to completion. A ... waxy surfactant found in many other preparations. Blocks ... Purity: ≥97% by titration. Contaminants: Heavy ...
... to help promote genomics-based research with S. aureus, ... that contains PCR primers to amplify all open ... addition, primer pairs are included to amplify ORFs ... N315 strains of S. aureus. The ORFmer set ...
... makes your life easier. It offers a wide array ... one balance. *Instruments supported: ... AG, XS, XP, PR, SR, PG-S, PG, SG, AT, ... User guidance on the ...
High affinity antibody reacting with S-100 ab heterodimer. Could be used for Western blotting application and immunoassay....
Biology Products: